Abbvie Inc Stock Current Asset
ABBV Stock | USD 180.35 1.16 0.65% |
AbbVie Inc fundamentals help investors to digest information that contributes to AbbVie's financial success or failures. It also enables traders to predict the movement of AbbVie Stock. The fundamental analysis module provides a way to measure AbbVie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbbVie stock.
Non Current Assets Total is likely to drop to about 57.7 B in 2024. Other Current Assets is likely to drop to about 3.5 B in 2024. AbbVie | Current Asset |
AbbVie Current Asset Analysis
AbbVie's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
More About Current Asset | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 19.8B | 22.5B | 30.7B | 32.2B | Total Assets | 146.5B | 138.8B | 134.7B | 81.2B |
Current Asset | = | Cash | + | Deposits | + | Liquid Assets |
Current AbbVie Current Asset | 16.31 B |
Most of AbbVie's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AbbVie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AbbVie Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for AbbVie is extremely important. It helps to project a fair market value of AbbVie Stock properly, considering its historical fundamentals such as Current Asset. Since AbbVie's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AbbVie's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AbbVie's interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
AbbVie Total Assets
Total Assets |
|
In accordance with the recently published financial statements, AbbVie Inc has a Current Asset of 16.31 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is 74.71% lower than that of the firm.
AbbVie Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbbVie's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics of similar companies.AbbVie is currently under evaluation in current asset category among related companies.
AbbVie ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AbbVie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AbbVie's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
AbbVie Fundamentals
Return On Equity | 0.35 | ||||
Return On Asset | 0.0807 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.32 % | ||||
Current Valuation | 363.85 B | ||||
Shares Outstanding | 1.77 B | ||||
Shares Owned By Insiders | 0.12 % | ||||
Shares Owned By Institutions | 71.89 % | ||||
Number Of Shares Shorted | 14.27 M | ||||
Price To Earning | 21.28 X | ||||
Price To Book | 30.63 X | ||||
Price To Sales | 5.85 X | ||||
Revenue | 54.32 B | ||||
Gross Profit | 41.53 B | ||||
EBITDA | 18.1 B | ||||
Net Income | 4.88 B | ||||
Cash And Equivalents | 11.88 B | ||||
Cash Per Share | 6.72 X | ||||
Total Debt | 59.38 B | ||||
Debt To Equity | 4.37 % | ||||
Current Ratio | 0.93 X | ||||
Book Value Per Share | 5.87 X | ||||
Cash Flow From Operations | 22.84 B | ||||
Short Ratio | 2.75 X | ||||
Earnings Per Share | 2.72 X | ||||
Price To Earnings To Growth | 0.49 X | ||||
Target Price | 184.03 | ||||
Number Of Employees | 50 K | ||||
Beta | 0.56 | ||||
Market Capitalization | 317.69 B | ||||
Total Asset | 134.71 B | ||||
Retained Earnings | (1000 M) | ||||
Working Capital | (4.84 B) | ||||
Current Asset | 16.31 B | ||||
Current Liabilities | 10.89 B | ||||
Z Score | 4.0 | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 4.33 % | ||||
Net Asset | 134.71 B | ||||
Last Dividend Paid | 5.99 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Non Current Assets Total | 101.7 B | 57.7 B | |
Other Current Assets | 4.9 B | 3.5 B | |
Total Current Assets | 33 B | 23.5 B |
Pair Trading with AbbVie
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.Moving together with AbbVie Stock
0.89 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against AbbVie Stock
0.9 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.9 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.82 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.81 | CALT | Calliditas Therapeutics Financial Report 21st of May 2024 | PairCorr |
0.8 | DBVT | DBV Technologies Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AbbVie Piotroski F Score and AbbVie Altman Z Score analysis. Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Dividend Share 5.99 | Earnings Share 2.72 | Revenue Per Share 30.723 | Quarterly Revenue Growth (0.05) |
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.